Developing a Peer Support Intervention for Depression in SCD
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age60+
SponsorMassachusetts General Hospital
About this trial
The purpose of this study is to assess the feasibility, acceptability, and fidelity of an 8-week intervention where peer coaches will deliver depression care to adults 60 years of age or older who have depression and subjective cognitive decline.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Older adults aged 60+
Endorse subjective cognitive decline
Endorse depressive symptoms
not currently experiencing suicidal ideation nor active, untreated manic, psychotic, or substance use disorder
Disqualifiers
Meets diagnostic criteria for mild cognitive impairment or Alzheimer's dementia
Meets diagnostic criteria for a current major depressive disorder
have a history of neurological and psychiatric comorbidities such as major depressive disorder in the past 12 months
Trial design
Design model
Single group
Treatments tested in this trial
PeersCOG
Behavioral. The intervention will consist of 8 weekly video chats focused on emotional, appraisal, and informational support delivered by community-based older adult peer coaches to adults 60 years of age and older with subthreshold depression and SCD.
Treatment groups
30 Participants
are divided into 1 treatment groupGroup A: InterventionOther 1 intervention
Trial outcomes
Primary outcomes
1
Feasibility of Intervention
Level of participant engagement: how many screened older adults agree to participate in the intervention and complete baseline assessments
Time frame
Measured at baseline enrollment2
Acceptability of Intervention
Number of meetings older adults complete with peer coach
Time frame
Measured during intervention (8 weeks)3
Fidelity of Intervention
Degree of adherence to intervention
Time frame
Measured during intervention (8 weeks)Sponsors and contacts
Click on the lead sponsor to view all of their trials.
Massachusetts General Hospital
Lead sponsor
National Institutes of Health (NIH)
Collaborator
Source ClinicalTrials.gov